GSA Capital Partners’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-17,468
| Closed | -$152K | – | 2039 |
|
|
2023
Q1 | $152K | Sell |
17,468
-48,861
| -74% | -$425K | 0.02% | 1304 |
|
|
2022
Q4 | $416K | Sell |
66,329
-32,700
| -33% | -$205K | 0.05% | 715 |
|
|
2022
Q3 | $347K | Buy |
99,029
+36,835
| +59% | +$129K | 0.05% | 830 |
|
|
2022
Q2 | $183K | Sell |
62,194
-130,050
| -68% | -$383K | 0.03% | 1094 |
|
|
2022
Q1 | $598K | Sell |
192,244
-38,014
| -17% | -$118K | 0.08% | 426 |
|
|
2021
Q4 | $778K | Sell |
230,258
-33,966
| -13% | -$115K | 0.1% | 329 |
|
|
2021
Q3 | $964K | Buy |
264,224
+133,552
| +102% | +$487K | 0.1% | 325 |
|
|
2021
Q2 | $570K | Sell |
130,672
-55,645
| -30% | -$243K | 0.06% | 547 |
|
|
2021
Q1 | $846K | Buy |
186,317
+33,520
| +22% | +$152K | 0.14% | 167 |
|
|
2020
Q4 | $877K | Buy |
+152,797
| New | +$877K | 0.14% | 170 |
|
|
2020
Q1 | – | Sell |
-197,290
| Closed | -$387K | – | 1666 |
|
|
2019
Q4 | $387K | Buy |
197,290
+151,187
| +328% | +$297K | 0.05% | 839 |
|
|
2019
Q3 | $236K | Buy |
46,103
+3,818
| +9% | +$19.5K | 0.03% | 1085 |
|
|
2019
Q2 | $303K | Buy |
+42,285
| New | +$303K | 0.03% | 997 |
|
|
2018
Q4 | – | Sell |
-62,500
| Closed | -$693K | – | 1827 |
|
|
2018
Q3 | $693K | Buy |
+62,500
| New | +$693K | 0.04% | 911 |
|
|
2018
Q1 | – | Sell |
-66,200
| Closed | -$609K | – | 1875 |
|
|
2017
Q4 | $609K | Sell |
66,200
-84,900
| -56% | -$781K | 0.04% | 844 |
|
|
2017
Q3 | $1.22M | Buy |
+151,100
| New | +$1.22M | 0.08% | 389 |
|